The Deal
Thursday, November 26, 
12:40 am

Entries tagged "Adolf Merckle"

Is the Alliance Boots-Phoenix rumor true?

Does Kohlberg Kravis Roberts & Co. want to merge its Alliance Boots GmbH wholesale pharmaceuticals business with Phoenix Pharmahandel AG & Co. KG?


Report: Auction block may be next step for Phoenix Pharma

German drug wholesaler Phoenix Pharmahandel AG may go on the auction block for as much as €6 billion ($7.8 billion) after founder Adolf Merckle committed suicide nearly two weeks ago, according to Bloomberg. ...


Merckle death is the end of an empire

With mounting debts exacerbated by a bad €1 billion ($1.35 billion) bet on shares of carmaker Volkswagen AG, German billionaire Adolf Merckle, who according to Forbes is the world's 94th wealthiest person, took his own life Monday. In a statement, the industrialist's family said the 74-year-old felt helpless by the process of trying to cover his bad investments. ...



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "Adolf Merckle." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: AlixPartners' Steve Deedy on Black Friday, the holiday season and retail bankruptcies.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

REIT IPO deja vu

By Edward Schneidman, Michael Blair and David Malinger, Mayer Brown

Real estate sponsors that might wish to undertake an IPO will need to consider a wide variety of issues and begin to take action long before the first filing with the SEC.


Industry Insight

Loan-to-buy

By Steven Miller, Standard & Poor's

Paulson's proposal to purchase an equity stake in Yellow Pages publisher Idearc is the second time in recent months an investor group has used its prepetition debt position to execute a bargain price 'exit LBO.'


Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.